Back to Search Start Over

Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

Authors :
Jang, Jae-Sik
Spertus, John A.
Arnold, Suzanne V.
Shafiq, Ali
Grodzinsky, Anna
Fendler, Timothy J.
Salisbury, Adam C.
Tang, Fengming
McNulty, Edward J.
Grantham, J. Aaron
Cohen, David J.
Amin, Amit P.
Source :
Journal of the American College of Cardiology (JACC). Nov2015, Vol. 66 Issue 19, p2104-2113. 10p.
Publication Year :
2015

Abstract

<bold>Background: </bold>Up to 65% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease (MVCAD). Long-term health status of STEMI patients after multivessel revascularization is unknown.<bold>Objectives: </bold>This study investigated the relationship between multivessel revascularization and health status outcomes (symptoms and quality of life [QoL]) in STEMI patients with MVCAD.<bold>Methods: </bold>Using a U.S. myocardial infarction registry and the Seattle Angina Questionnaire (SAQ), we determined the health status of patients with STEMI and MVCAD at the time of STEMI and 1 year later. We assessed the association of multivessel revascularization during index hospitalization with 1-year health status using multivariable linear regression analysis, and also examined demographic, clinical, and angiographic factors associated with multivessel revascularization.<bold>Results: </bold>Among 664 STEMI patients with MVCAD, 251 (38%) underwent multivessel revascularization. Most revascularizations were staged during the index hospitalization (64.1%), and 8.0% were staged after discharge, with 27.9% performed during primary percutaneous coronary intervention. Multivessel revascularization was associated with age and more diseased vessels. At 1 year, multivessel revascularization was independently associated with improved symptoms (4.5 points higher SAQ angina frequency score; 95% confidence interval [CI]: 1.0 to 7.9) and QoL (6.6 points higher SAQ QoL score; 95% CI: 2.7 to 10.6). One-year mortality was not different between those who did and did not undergo multivessel revascularization (3.6% vs. 3.4%; log-rank test p = 0.88).<bold>Conclusions: </bold>Multivessel revascularization improved angina and QoL in STEMI patients with MVCAD. Patient-centered outcomes should be considered in future trials of multivessel revascularization. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
07351097
Volume :
66
Issue :
19
Database :
Academic Search Index
Journal :
Journal of the American College of Cardiology (JACC)
Publication Type :
Academic Journal
Accession number :
110576387
Full Text :
https://doi.org/10.1016/j.jacc.2015.08.873